Rigel Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment o…

Biotechnology
US, South San Francisco [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of RIGL's Analysis
CIK: 1034842 CUSIP: 766559603 ISIN: US7665596034 LEI: - UEI: -
Secondary Listings
RIGL has no secondary listings inside our databases.